Vikram Karnani
Chief Tech/Sci/R&D Officer bei HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Profil
Vikram Karnani is currently the President-International, Medical Affairs & EVP at Horizon Therapeutics Plc.
Previously, he worked as the VP-Therapeutics & Cell Therapy Business at Fresenius Kabi USA LLC from 2008 to 2014.
He holds a graduate degree from Case Western Reserve University, an undergraduate degree from the University of Mumbai, and an MBA from Kellogg School of Management.
Aktive Positionen von Vikram Karnani
| Unternehmen | Position | Beginn |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Vikram Karnani
| Unternehmen | Position | Ende |
|---|---|---|
Fresenius Kabi USA LLC
 Fresenius Kabi USA LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi USA LLC provides healthcare products and services. It specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The firm''s products are used to help care for critically and chronically ill patients. The company was founded by Eduard Fresenius in 1912 and is headquartered in Lake Zurich, IL. | Corporate Officer/Principal | 01.08.2014 |
Ausbildung von Vikram Karnani
| Case Western Reserve University | Graduate Degree |
| University of Mumbai | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Fresenius Kabi USA LLC
Fresenius Kabi USA LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi USA LLC provides healthcare products and services. It specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The firm''s products are used to help care for critically and chronically ill patients. The company was founded by Eduard Fresenius in 1912 and is headquartered in Lake Zurich, IL. | Health Technology |
